2018 MSK Cardio-Oncology Symposium - Cardiovascular Health and Disease During and After Cancer Therapy: A case-based curriculum

2018 MSK Cardio-Oncology Symposium - Cardiovascular Health and Disease During and After Cancer Therapy: A case-based curriculum is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held during May 18 - 19, 2018 at Rockefeller Research Laboratories, New York City, New York, United States of America.

The target audience for this medical event is cardiologists, internists, hematologists/oncologists and other affiliated healthcare professionals who are involved in the care of cancer patients or have a special interest in this area.

Lectures AMA Credit Designation Statement:
This CME Conference has been approved for a maximum of 14.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Workshop AMA Credit Designation Statement:
This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conference Description :
Over the past decade, the cardiovascular care of patients with cancer has evolved as a subspecialty driven by novel therapies that can cure or control patients, allowing many patients to be living long enough to experience the potential cardiotoxic effects of these treatments. The purpose of this conference is to provide a case-based curriculum that addresses important clinical topics relevant to the cardiovascular health of patients with cancer.

Clinical experts from Memorial Sloan Kettering Cancer Center and around the country will present an up-to-date overview on the best practice strategies in the evaluation and management of heart disease in cancer patients from early diagnosis, treatment and long-term surveillance. All presentations will include devoted time to permit interaction between audience members and presenters. There will be a separate computer-based session on how to perform and analyze global longitudinal strain (details below).

Computer Based Hands-On Learning Lab (Optional) :
The aim of the learning lab is to provide participants personalized hands-on experience in GLS performance and analysis. Following an introductory lecture on the clinical application of strain, participants will analyze real cases pre-loaded on their own computer workstation under the supervision of the faculty. Tips on acquiring optimal 2D images for speckle tracking and step-by-step how to perform and analyze 2D GLS will be demonstrated with examples of common pitfalls to avoid. Seating is limited to allow each participant sufficient opportunity to interact with faculty.

Conference Objectives are :
• State best practice strategies in cardiotoxicity monitoring and management for patients receiving breast cancer treatment.
• Recognize the cardiovascular concerns with conventional and newer targeted therapy used to treat cancer and the timeline of the cardiotoxicity manifestation.
• Describe emerging cardiotoxicity associated with immunotherapy and management of immunotherapy related myocarditis.
• State specific examples of cardiovascular challenges during cancer therapy.
• Describe radiation induced heart disease and recognize the development of practice change in radiotherapy over time
• Illustrate the utility of preclinical biomarkers for cardiotoxicity monitoring.
• Define the role of imaging studies in the detection and prediction of cardiotoxicity.
• Identify late onset cardiotoxicity in adult survivors of childhood cancer.
• Discuss the implementation of cardio-oncology practice guidelines to formulate best practice strategies.
• State the goals and principles of a multidisciplinary team in cardio-oncology and the approach to building a cardio-oncologic clinic